Seifem Surveillance of Antifungal Combination Therapy In Hematologic Italian Centers

Fungal Infection Clinical Trial

— SEIFEM COMBO  

Official title:

Seifem Observational Study of Antifungal Combination Therapy In Hematologic Italian Centers

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00906633
• Other study ID #: SEIFEMcombo0509
• Status: Completed
• Phase: N/A
• First received: May 19, 2009
• Last updated: January 25, 2010
• Start date: January 2009
• Est. completion date: January 2010

Study information

• Verified date: May 2009
• Source: University Hospital, Udine, Italy
• Contact: n/a
• Is FDA regulated: No
• Health authority: Italy: Ethics Committee
• Study type: Observational

Clinical Trial Summary

This trial is an observational study about combination antifungal therapy in hematologic patients with proven and probable invasive fungal infections (IFI).

Recruitment information / eligibility

• Status: Completed
• Enrollment: 80
• Est. completion date: January 2010
• Est. primary completion date: December 2009
• Accepts healthy volunteers: No
• Gender: Both
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• Haematologic patients with proven or probable IFI

• Therapy with a combination of antifungal drugs

Exclusion Criteria:

• Haematologic patients with possible IFI

Study Design

Observational Model: Case-Only, Time Perspective: Prospective

Related Conditions & MeSH terms

• Fungal Infection
• Mycoses

Locations

Country	Name	City	State
Italy	University Hospital, Udine	Udine

Sponsors (2)

Lead Sponsor	Collaborator
University Hospital, Udine, Italy	Catholic University of the Sacred Heart

Country where clinical trial is conducted

Italy, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	safety, efficacy and duration of therapy		one year	No